Initial single-pill combination therapy for cardiovascular risk factor management: It is not just convenience

Journal of Hypertension

Volumn 31, Issue 8, 2013, Pages 1537-1538

  Briasoulis, Alexandros ^a   Bakris, George ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE PLUS ATORVASTATIN;

BLOOD PRESSURE; CARDIOVASCULAR RISK; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; NOTE; PILL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZATION; RISK MANAGEMENT; SINGLE PILL COMBINATION THERAPY; SYSTOLIC BLOOD PRESSURE;

EID: 84880517700     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328361d016     Document Type: Note

References (13)

1. Epstein M, Bakris G. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy. Arch Intern Med 1996; 156: 1969-1978.
2. Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med 2009; 122:290-300.
3. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981-2997.
4. Gradman AH, Basile JN, Carter BL, Bakris GL. Combination therapy in hypertension. J Clin Hypertens (Greenwich) 2011; 13:146-154.
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
6. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial, HOT Study Group. Lancet 1998; 351:1755-1762.
7. Jamerson K, Weber MA, Bakris GL, Dahlof B, Pitt B, Shi V, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359:2417-2428.
8. Bakris G, Hill M, Mancia G, Steyn K, Black HR, Pickering T, et al. Achieving blood pressure goals globally: five core actions for healthcare professionals. A worldwide call to action. J Hum Hypertens 2008; 22:63-70.
9. Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins SR, Battleman DS, et al. Predictors of adherence with antihypertensive and lipidlowering therapy. Arch Intern Med 2005; 165:1147-1152.
10. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007; 120:713-719.
11. Feldman RD, Zou GY, Vandervoort MK, Wong CJ, Nelson SA, Feagan BG. A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension 2009; 53:646-653.
12. Dresser GK, Nelson SAE, Mahon JL, Zou G, Vandervoort MK, Wong CJ, et al. Simplified therapeutic intervention to control hypertension and hypercholesterolemia: a cluster randomized controlled trial (STITCH2). J Hypertens 2013; 31:1702-1713.
13. Alonso Moreno FJ, Llisterri Caro JL, Rodriguez Roca GC, Prieto Diaz MA, Divison Garrote JA, Barrios AV, et al. [Medical conduct in primary care as regards blood pressure control. PRESCAP 2010 Study]. Semergen 2013; 39:3-11.